Holen Sie sich die Stockscreener-App
13.96
3.66%
-0.531
Schlusskurs vom Vortag:
$14.49
Offen:
$13.8
24-Stunden-Volumen:
8,088
Relative Volume:
1.01
Marktkapitalisierung:
$30.66M
Einnahmen:
$8.50M
Nettoeinkommen (Verlust:
$-10.94M
KGV:
-1.8441
EPS:
-7.57
Netto-Cashflow:
$-28.76M
1W Leistung:
+1.23%
1M Leistung:
-6.93%
6M Leistung:
-7.43%
1J Leistung:
+119.67%
1-Tages-Spanne:
$12.88
$13.96
1-Wochen-Bereich:
$12.88
$15.29
52-Wochen-Spanne:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
13.96 | 30.42M | 8.50M | -10.94M | -28.76M | -7.57 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Apollomics Inc Aktie (APLM) Neueste Nachrichten
Apollomics Inc. (APLM) Faces Pressure Amid Recent Decline – Key Levels to WatchBearish Pattern Stocks - newsline.com
Behavioral Patterns of APLM and Institutional Flows - Stock Traders Daily
[EFFECT] Apollomics Inc. SEC Filing - Stock Titan
APLM SEC FilingsAPOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Apollomics Inc. (APLM) Edges Higher as Stock Tests Resistance Near $14.86Volume Profile - The Legal Advocate
(APLM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Apollomics Inc. Warrant (APLMW) Trades Flat at $0.01 Amid Minimal ActivityLow Volatility Picks - newsline.com
Apollomics Inc. Warrant (APLMW) Stalls at $0.01: Micro-Cap Warrant Holds Steady Amid Minimal Trading ActivitySmart Beta Flow - The Legal Advocate
Apollomics Inc. Warrant (APLMW) Holds Steady Near Minimal Levels – A Closer Look at the Biotech DerivativeCup and Handle - The Legal Advocate
Apollomics Warrants (APLMW) Hold at $0.01 After Modest Gain – Tight Trading Range PersistsCommunity Buy Alerts - Newser
APLMW Technical Analysis | Trend, Signals & Chart Patterns | APOLLOMICS INC-27 (NASDAQ:APLMW) - ChartMill
Apollomics Inc. (APLMW) Warrants Trade at $0.01 After Double-Digit DeclineSell Signal Alerts - Newser
Apollomics (APLM) director converts 500 RSUs into Class A shares - Stock Titan
How (APLM) Movements Inform Risk Allocation Models - Stock Traders Daily
Apollomics Inc. (APLM) files F-3/A to register 279,775 Class A shares - Stock Titan
Is Apollomics (APLM) Still a Buy After +10.29% Rally? 2026-05-15Investment Picks - newser.com
Apollomics (APLM) Climbs +0.54% — Resistance at $14.28 in Focus 2026-05-14Social Buy Zones - newser.com
TradingKey - TradingKey
What to expect when Apollomics (APLMW) reports earnings |Hold Rating - Newser
Trading Systems Reacting to (APLM) Volatility - Stock Traders Daily
The labor dynamics in Apollomics (APLM) results |Inventory Turnover - newser.com
APLMW | Apollomics Inc. Warrant Insider Trading - Quiver Quantitative
Is Apollomics (APLMW) dividend sustainable? (Smart Money Exits) 2026-04-29Expert Verified Trades - newser.com
Apollomics (Nasdaq: APLM) slashes 2025 loss amid cost cuts and new vebreltinib deal revenue - Stock Titan
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress - marketscreener.com
How Apollomics Inc. (APLM) Affects Rotational Strategy Timing - Stock Traders Daily
APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report.Gamma Squeeze - Newser
APLM: Strategic restructuring and licensing revenue reduced losses, but liquidity and going concern risks persist - TradingView
Apollomics (NASDAQ: APLM) warns on going concern, defers vebreltinib NDA and writes down asset - Stock Titan
Apollomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Apollomics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
APLM Forecast — Price Target — Prediction for 2027 - TradingView
Apollomics Inc. Warrant (APLMW) - Minichart
Apollomics (APLM) Stock: Is It a Smart Investment (Slight Loss) 2026-04-18Crowd Entry Signals - Cổng thông tin điện tử tỉnh Lào Cai
Hong Jung Chen Net Worth (2026) - GuruFocus
Ya Chi Huang Net Worth (2026) - GuruFocus
Peter Kuan How Lin Net Worth (2026) - GuruFocus
Yi Kuei Chen Net Worth (2026) - GuruFocus
Chen Huan Jan Net Worth (2026) - GuruFocus
Hsien Shu Tsai Net Worth (2026) - GuruFocus
Apollomics (APLM) director details RSUs, options and warrants in Form 3/A - Stock Titan
Apollomics (APLM) CFO has shares withheld for RSU tax obligations - Stock Titan
(APLM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
[Form 3/A] Apollomics Inc. Amended Initial Statement of Beneficial Ownership - Stock Titan
Apollomics (APLM) director Jan Chen-Huan reports 1,000 RSUs and 1,000 shares - Stock Titan
Apollomics (APLM) CFO details 20,000 RSUs and 15,900 shares in Form 3/A - Stock Titan
Apollomics (ticker: APLM) CEO details direct and indirect share stakes - Stock Titan
Apollomics (APLM) director discloses 1,000 restricted stock units award - Stock Titan
Apollomics (APLM) COO details RSU grants and Maxpro warrant stakes - Stock Titan
Apollomics (APLM) director Huang Ya-Chi details RSU vesting and share holdings - Stock Titan
Tech Rally: Does Apollomics Inc Equity Warrant have pricing power2026 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn
Finanzdaten der Apollomics Inc-Aktie (APLM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Apollomics Inc-Aktie (APLM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| CHU YI-AN | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,500 |
| CHEN HONG-JUNG | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
3,620 |
| TSAI HSIEN-SHU | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,500 |
| Chen Yi-Kuei | Chief Operating Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
5,000 |
0 |
15,000 |
| Jan Chen-Huan | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,500 |
| Huang Ya-Chi | Director |
May 17 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,000 |
2.60%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):